Angiotensin converting enzyme inhibitors in congestive heart failure: Overview in comparison of captopril and enalapril

This publication has 19 references indexed in Scilit:

• Introduction
  The American Journal of Cardiology, 1985
• Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
  Circulation, 1984
• Increased plasma arginine vasopressin levels in patients with congestive heart failure
  Journal of the American College of Cardiology, 1983
• Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
  The American Journal of Cardiology, 1982
• Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
  Circulation, 1980
• Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
  Circulation, 1980
• SEQUENTIAL CHANGES IN CIRCULATING LEVELS OF ANGIOTENSIN I AND II, RENIN, AND BRADYKININ AFTER CAPTOPRIL
  The Medical Journal of Australia, 1979
• Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
  Circulation, 1978
• A Specific Competitive Antagonist of the Vascular Action of Angiotensin II
  Circulation Research, 1971
• Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin II
  Circulation, 1962